Cather Simpson
Cather Simpson
Pacific Channel Partner
Cather Simpson is a partner at Pacific Channel, a Professor of Physics and Chemical Sciences at the University of Auckland, and acting CEO/CSO of Orbis Diagnostics. She moved to New Zealand in 2007 from the USA, where she was tenured faculty at Case Western Reserve University. At the University of Auckland, she founded and directed the Photon Factory, an outwardly facing laser R&D centre in the Faculty of Science. In 2018 she stepped down as Director to serve 3 years as Chief Science Officer of Engender Technologies, one of the Photon Factory’s startups. As a researcher in Chemical Physics and a founder or co-founder to three high-tech startups, she is keenly interested in the interface between academic research and commercialisation.
Cather is a Fellow of the Royal Society Te Aparangi where she currently sits on the Academy Executive. She is a Director of SPIE (International Society for Optics & Photonics), Fisher & Paykel Healthcare, Advemto, and Orbis Diagnostics. Accolades include a New Zealand National Teaching Award and the Royal Society’s Pickering Medal. She was named the 2022 KiwiNet Commercialisation Icon and in 2023 was awarded the inaugural New Zealand Institute of Physics Te Tohu mo te Whaihua i te Matai Ahupungao —Physics Impact Award. Cather is quoted as saying "I am not built for my dream career, which was to be a professional basketball player," so she's been instead making incomparable contributions to NZ physics and entrepreneurship.
Cather is a Fellow of the Royal Society Te Aparangi where she currently sits on the Academy Executive. She is a Director of SPIE (International Society for Optics & Photonics), Fisher & Paykel Healthcare, Advemto, and Orbis Diagnostics. Accolades include a New Zealand National Teaching Award and the Royal Society’s Pickering Medal. She was named the 2022 KiwiNet Commercialisation Icon and in 2023 was awarded the inaugural New Zealand Institute of Physics Te Tohu mo te Whaihua i te Matai Ahupungao —Physics Impact Award. Cather is quoted as saying "I am not built for my dream career, which was to be a professional basketball player," so she's been instead making incomparable contributions to NZ physics and entrepreneurship.
Connect
Related Sessions
New Zealand Innovators Changing the World
WED, OCT 18, 2:00 PM
Conference
The New Zealand Innovation ecosystem has benefited from over a decade of growth. In the last 10 years we have become world-renown from our science and engineering capabilities (deeptech), growing companies like Aroa Biosurgery, Mint Innovation, and Rocket Lab, amongst others.
The world needs science innovation more than ever, and as we acknowledge the urgency of developing solutions that tackle our biggest issues, a new generation of entrepreneurs as arisen, focusing on Biotechnology, Energy/Cleantech, Agriculture, and Innovative Manufacturing.
In this session you will hear the experiences of the entrepreneurs’ scaling companies from New Zealand going global. The inspiration behind their founder journeys, their biggest learnings while building companies that stand the test of time, and how do they manage to drive change in this economic environment.
New Zealand Venture Capital: Funding the Next Generation of Innovators
THU, OCT 19, 10:30 AM
Conference
The New Zealand innovation ecosystem has benefited from over a decade of growth. In the last 10 years we have seen the Venture Capital scene go from inception to a vibrant market with almost 30 different funds investing in the companies of tomorrow.
But after the SaaS successes of the likes of TradeMe, Xero, Vend, and Timely, investors and entrepreneurs are chasing the next unicorn company that is using science and engineering to change the world. Taking deeptech companies from lab to market, is not an easy task, and it requires large amounts of patient capital.
In this session you will hear the biggest learnings, challenges, and anecdotes from the investors backing the deeptech companies taking New Zealand to the forefront of innovation. You will hear about what investors look for when backing ambitious founders, what to think of when translating your research into a commercial endeavour, and tips and tricks from failed experiences.
